MANCUSO, KATIA
MANCUSO, KATIA
DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
Ricercatori a tempo determinato
A prospective, multicenter study on hematopoietic stem-cell mobilization with cyclophosphamide plus granulocyte colony-stimulating factor and 'on-demand' plerixafor in multiple myeloma patients treated with novel agents
2024 Mina, Roberto; Petrucci, Maria Teresa; Bonello, Francesca; Bongarzoni, Velia; Saccardi, Riccardo; Bertuglia, Giuseppe; Mengarelli, Andrea; Spadaro, Andrea; Lisi, Chiara; Curci, Paola; Lemoli, Roberto Massimo; Ballanti, Stelvio; Floris, Rita; Cupelli, Luca; Tosi, Patrizia; Olivieri, Attilio; Rota-Scalabrini, Delia; Cangialosi, Clotilde; Nozzoli, Chiara; Anaclerico, Barbara; Fazio, Francesca; Bruno, Benedetto; Mancuso, Katia; Corradini, Paolo; Milone, Giuseppe; Boccadoro, Mario
Impact of Anti-CD38 Monoclonal Antibody Therapy on CD34+ Hematopoietic Stem Cell Mobilization, Collection, and Engraftment in Multiple Myeloma Patients—A Systematic Review
2024 Bigi F.; Manzato E.; Barbato S.; Talarico M.; Puppi M.; Masci S.; Sacchetti I.; Restuccia R.; Iezza M.; Rizzello I.; Sartor C.; Mancuso K.; Pantani L.; Tacchetti P.; Cavo M.; Zamagni E.
Multi-dimensional scaling techniques unveiled gain1q&loss13q co-occurrence in Multiple Myeloma patients with specific genomic, transcriptional and adverse clinical features
2024 Terragna C.; Poletti A.; Solli V.; Martello M.; Zamagni E.; Pantani L.; Borsi E.; Vigliotta I.; Mazzocchetti G.; Armuzzi S.; Taurisano B.; Testoni N.; Marzocchi G.; Kanapari A.; Pistis I.; Tacchetti P.; Mancuso K.; Rocchi S.; Rizzello I.; Cavo M.
Predictors of early morbidity and mortality in newly diagnosed multiple myeloma: data from five randomized, controlled, phase III trials in 3700 patients
2024 Mai E.K.; Hielscher T.; Bertsch U.; Salwender H.J.; Zweegman S.; Raab M.S.; Munder M.; Pantani L.; Mancuso K.; Brossart P.; Beksac M.; Blau I.W.; Durig J.; Besemer B.; Fenk R.; Reimer P.; van der Holt B.; Hanel M.; von Metzler I.; Graeven U.; Muller-Tidow C.; Boccadoro M.; Scheid C.; Dimopoulos M.A.; Hillengass J.; Weisel K.C.; Cavo M.; Sonneveld P.; Goldschmidt H.
Predictors of unsustained measurable residual disease negativity in patients with multiple myeloma
2024 D'Agostino M.; Bertuglia G.; Rota-Scalabrini D.; Belotti A.; Morè S.; Corradini P.; Oliva S.; Ledda A.; Grasso M.; Pavone V.; Ronconi S.; Vincelli I.D.; Ballanti S.; Velluti C.; Cellini C.; Gozzetti A.; Palmas A.D.; Gamberi B.; Mancuso K.; Paris L.; Zambello R.; Petrucci M.T.; Bruno B.; Musto P.; Gay F.
Severe SARS-CoV-2 and subsequent fungal infections after CAR T-cell therapy for relapsed/refractory multiple myeloma: a challenging and happy ending fight
2024 Ielo, Claudia; Fazio, Francesca; Rocchi, Serena; Rizzello, Ilaria; Mancuso, Katia; Zamagni, Elena; Cavo, Michele; Petrucci, Maria Teresa
Single-Cell DNA Sequencing Reveals an Evolutionary Pattern of CHIP in Transplant Eligible Multiple Myeloma Patients
2024 Borsi, Enrica; Vigliotta, Ilaria; Poletti, Andrea; Mazzocchetti, Gaia; Solli, Vincenza; Zazzeroni, Luca; Martello, Marina; Armuzzi, Silvia; Taurisano, Barbara; Kanapari, Ajsi; Pistis, Ignazia; Zamagni, Elena; Pantani, Lucia; Rocchi, Serena; Mancuso, Katia; Tacchetti, Paola; Rizzello, Ilaria; Rizzi, Simonetta; Dan, Elisa; Sinigaglia, Barbara; Cavo, Michele; Terragna, Carolina
High levels of CRBN isoform lacking IMiDs binding domain predicts for a worse response to IMiDs-based upfront therapy in newly diagnosed myeloma patients
2023 Borsi E.; Mazzocchetti G.; Dico A.F.; Vigliotta I.; Martello M.; Poletti A.; Solli V.; Armuzzi S.; Taurisano B.; Kanapari A.; Pistis I.; Zamagni E.; Tacchetti P.; Pantani L.; Mancuso K.; Rocchi S.; Rizzello I.; Cavo M.; Terragna C.
Impact of minimal residual disease standardised assessment by FDG-PET/CT in transplant-eligible patients with newly diagnosed multiple myeloma enrolled in the imaging sub-study of the FORTE trial
2023 Zamagni E.; Oliva S.; Gay F.; Capra A.; Rota-Scalabrini D.; D'Agostino M.; Belotti A.; Galli M.; Racca M.; Zambello R.; Gamberi B.; Albano D.; Bertamini L.; Versari A.; Grasso M.; Sgherza N.; Priola C.; Fioritoni F.; Patriarca F.; De Cicco G.; Villanova T.; Pascarella A.; Zucchetta P.; Tacchetti P.; Fanti S.; Mancuso K.; Barbato S.; Boccadoro M.; Musto P.; Cavo M.; Nanni C.
Long term follow-up of humoral and cellular response to mRNA-based vaccines for SARS-CoV-2 in patients with active multiple myeloma
2023 Mancuso K.; Zamagni E.; Solli V.; Gabrielli L.; Leone M.; Pantani L.; Rocchi S.; Rizzello I.; Tacchetti P.; Ghibellini S.; Favero E.; Ursi M.; Talarico M.; Barbato S.; Kanapari A.; Bigi F.; Puppi M.; Terragna C.; Borsi E.; Martello M.; Poletti A.; Scata A.; Nepoti G.; Ruffini B.; Lazzarotto T.; Cavo M.
Multidisciplinary Management of Sternal Osteomyelitis Due to Klebsiella aerogenes after Open Heart Surgery in a Patient with Multiple Myeloma: A Case Report and Discussion of the Literature
2023 Pignatti, Marco; Dolci, Giampiero; Zamagni, Elena; Pascale, Renato; Piccin, Ottavio; Ammar, Alessandro; Zeneli, Flavia; Miralles, Maria Elisa Lozano; Mancuso, Katia; Cipriani, Riccardo; Viale, Pierluigi; Pacini, Davide; Martin-Suàrez, Sofia
Pomalidomide combinations are a safe and effective option after daratumumab failure
2023 Annamaria Brioli; Laura Gengenbach; Katia Mancuso; Mascha Binder; Thomas Ernst; Florian H. Heidel; Thomas Stauch; Elena Zamagni; Inken Hilgendorf; Andreas Hochhaus; Monika Engelhardt; Marie von Lilienfeld-Toal
Prospective phase 2 trial of daratumumab with dexamethasone in patients with relapsed/refractory multiple myeloma and severe renal impairment or on dialysis: The DARE study
2023 Kastritis E.; Terpos E.; Symeonidis A.; Labropoulou V.; Delimpasi S.; Mancuso K.; Zamagni E.; Katodritou E.; Rivolti E.; Kyrtsonis M.-C.; Roussou M.; Fotiou D.; Theodorakakou F.; Ntanasis-Stathopoulos I.; Hatjiharissi E.; Kanellias N.; Migkou M.; Cheliotis G.; Manousou K.; Gavriatopoulou M.; Dimopoulos M.A.
Treatment of primary plasma cell leukaemia with carfilzomib and lenalidomide-based therapy (EMN12/HOVON-129): final analysis of a non-randomised, multicentre, phase 2 study
2023 van de Donk NWCJ, Minnema MC, van der Holt B, Schjesvold F, Wu KL, Broijl A, Roeloffzen WWH, Gadisseur A, Pietrantuono G, Pour L, van der Velden VHJ, Lund T, Offidani M, Grasso M, Giaccone L, Razawy W, Tacchetti P, Mancuso K, Silkjaer T, Caers J, Zweegman S, Hájek R, Benjamin R, Vangsted AJ, Boccadoro M, Gay F, Sonneveld P, Musto P
Carfilzomib combined with lenalidomide and dexamethasone (KRd) as salvage therapy for multiple myeloma patients: italian, multicenter, retrospective clinical experience with 600 cases outside of controlled clinical trials
2022 Martino E.A.; Conticello C.; Zamagni E.; Pavone V.; Palmieri S.; Musso M.; Tacchetti P.; Mele A.; Catalano L.; Vigna E.; Bruzzese A.; Mendicino F.; Botta C.; Vincelli I.D.; Farina G.; Barone M.; Cangialosi C.; Mancuso K.; Rizziello I.; Rocchi S.; Falcone A.P.; Mele G.; Reddiconto G.; Garibaldi B.; Iaccino E.; Tripepi G.; Gamberi B.; Di Raimondo F.; Musto P.; Neri A.; Cavo M.; Morabito F.; Gentile M.
Clonal and subclonal TP53 molecular impairment is associated with prognosis and progression in multiple myeloma
2022 Martello M.; Poletti A.; Borsi E.; Solli V.; Dozza L.; Barbato S.; Zamagni E.; Tacchetti P.; Pantani L.; Mancuso K.; Vigliotta I.; Rizzello I.; Rocchi S.; Armuzzi S.; Testoni N.; Marzocchi G.; Martinelli G.; Cavo M.; Terragna C.
Identification of a Maturation Plasma Cell Index through a Highly Sensitive Droplet Digital PCR Assay Gene Expression Signature Validation in Newly Diagnosed Multiple Myeloma Patients
2022 Martello M.; Solli V.; Termini R.; Kanapari A.; Remondini D.; Borsi E.; Poletti A.; Armuzzi S.; Taurisano B.; Vigliotta I.; Mazzocchetti G.; Zamagni E.; Merlotti A.; Tacchetti P.; Pantani L.; Rocchi S.; Rizzello I.; Mancuso K.; Cavo M.; Terragna C.
Role of serum-free light chain assay for defining response and progression in immunoglobulin secretory multiple myeloma
2022 Tacchetti P.; Rocchi S.; Zamagni E.; Barbato S.; Rizzello I.; De Cicco G.; Pantani L.; Mancuso K.; Fusco A.; Dozza L.; Ursi M.; Favero E.; Terragna C.; Testoni N.; Cavo M.
The ALLgorithMM: How to define the hemodilution of bone marrow samples in lymphoproliferative diseases
2022 Vigliotta, Ilaria; Armuzzi, Silvia; Barone, Martina; Solli, Vincenza; Pistis, Ignazia; Borsi, Enrica; Taurisano, Barbara; Mazzocchetti, Gaia; Martello, Marina; Poletti, Andrea; Sartor, Chiara; Rizzello, Ilaria; Pantani, Lucia; Tacchetti, Paola; Papayannidis, Cristina; Mancuso, Katia; Rocchi, Serena; Zamagni, Elena; Curti, Antonio; Arpinati, Mario; Cavo, Michele; Terragna, Carolina
A real-world efficacy and safety analysis of combined carfilzomib, lenalidomide, and dexamethasone (KRd) in relapsed/refractory multiple myeloma
2021 Rocchi S.; Tacchetti P.; Pantani L.; Mancuso K.; Rizzello I.; di Giovanni Bezzi C.; Scalese M.; Dozza L.; Marzocchi G.; Martello M.; Barila G.; Antonioli E.; Staderini M.; Buda G.; Petrini M.; Cea M.; Quaresima M.; Furlan A.; Bonalumi A.; Cavo M.; Zamagni E.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| A prospective, multicenter study on hematopoietic stem-cell mobilization with cyclophosphamide plus granulocyte colony-stimulating factor and 'on-demand' plerixafor in multiple myeloma patients treated with novel agents | Mina, Roberto; Petrucci, Maria Teresa; Bonello, Francesca; Bongarzoni, Velia; Saccardi, Riccardo;... Bertuglia, Giuseppe; Mengarelli, Andrea; Spadaro, Andrea; Lisi, Chiara; Curci, Paola; Lemoli, Roberto Massimo; Ballanti, Stelvio; Floris, Rita; Cupelli, Luca; Tosi, Patrizia; Olivieri, Attilio; Rota-Scalabrini, Delia; Cangialosi, Clotilde; Nozzoli, Chiara; Anaclerico, Barbara; Fazio, Francesca; Bruno, Benedetto; Mancuso, Katia; Corradini, Paolo; Milone, Giuseppe; Boccadoro, Mario | 2024-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | 11344-Article Text-82608-2-10-20240422.pdf |
| Impact of Anti-CD38 Monoclonal Antibody Therapy on CD34+ Hematopoietic Stem Cell Mobilization, Collection, and Engraftment in Multiple Myeloma Patients—A Systematic Review | Bigi F.; Manzato E.; Barbato S.; Talarico M.; Puppi M.; Masci S.; Sacchetti I.; Restuccia R.; Iez...za M.; Rizzello I.; Sartor C.; Mancuso K.; Pantani L.; Tacchetti P.; Cavo M.; Zamagni E. | 2024-01-01 | PHARMACEUTICALS | - | 1.01 Articolo in rivista | pharmaceuticals-17-00944.pdf; pharmaceuticals-17-00944-s001.zip |
| Multi-dimensional scaling techniques unveiled gain1q&loss13q co-occurrence in Multiple Myeloma patients with specific genomic, transcriptional and adverse clinical features | Terragna C.; Poletti A.; Solli V.; Martello M.; Zamagni E.; Pantani L.; Borsi E.; Vigliotta I.; M...azzocchetti G.; Armuzzi S.; Taurisano B.; Testoni N.; Marzocchi G.; Kanapari A.; Pistis I.; Tacchetti P.; Mancuso K.; Rocchi S.; Rizzello I.; Cavo M. | 2024-01-01 | NATURE COMMUNICATIONS | - | 1.01 Articolo in rivista | 41467_2024_Article_45000.pdf; 41467_2024_45000_MOESM7_ESM.zip |
| Predictors of early morbidity and mortality in newly diagnosed multiple myeloma: data from five randomized, controlled, phase III trials in 3700 patients | Mai E.K.; Hielscher T.; Bertsch U.; Salwender H.J.; Zweegman S.; Raab M.S.; Munder M.; Pantani L....; Mancuso K.; Brossart P.; Beksac M.; Blau I.W.; Durig J.; Besemer B.; Fenk R.; Reimer P.; van der Holt B.; Hanel M.; von Metzler I.; Graeven U.; Muller-Tidow C.; Boccadoro M.; Scheid C.; Dimopoulos M.A.; Hillengass J.; Weisel K.C.; Cavo M.; Sonneveld P.; Goldschmidt H. | 2024-01-01 | LEUKEMIA | - | 1.01 Articolo in rivista | Mai_2024.pdf; 41375_2023_2105_MOESM1_ESM.pdf |
| Predictors of unsustained measurable residual disease negativity in patients with multiple myeloma | D'Agostino M.; Bertuglia G.; Rota-Scalabrini D.; Belotti A.; Morè S.; Corradini P.; Oliva S.; Led...da A.; Grasso M.; Pavone V.; Ronconi S.; Vincelli I.D.; Ballanti S.; Velluti C.; Cellini C.; Gozzetti A.; Palmas A.D.; Gamberi B.; Mancuso K.; Paris L.; Zambello R.; Petrucci M.T.; Bruno B.; Musto P.; Gay F. | 2024-01-01 | BLOOD | - | 1.01 Articolo in rivista | - |
| Severe SARS-CoV-2 and subsequent fungal infections after CAR T-cell therapy for relapsed/refractory multiple myeloma: a challenging and happy ending fight | Ielo, Claudia; Fazio, Francesca; Rocchi, Serena; Rizzello, Ilaria; Mancuso, Katia; Zamagni, Elena...; Cavo, Michele; Petrucci, Maria Teresa | 2024-01-01 | LEUKEMIA RESEARCH REPORTS | - | 1.01 Articolo in rivista | Severe SARS-CoV-2.pdf |
| Single-Cell DNA Sequencing Reveals an Evolutionary Pattern of CHIP in Transplant Eligible Multiple Myeloma Patients | Borsi, Enrica; Vigliotta, Ilaria; Poletti, Andrea; Mazzocchetti, Gaia; Solli, Vincenza; Zazzeroni..., Luca; Martello, Marina; Armuzzi, Silvia; Taurisano, Barbara; Kanapari, Ajsi; Pistis, Ignazia; Zamagni, Elena; Pantani, Lucia; Rocchi, Serena; Mancuso, Katia; Tacchetti, Paola; Rizzello, Ilaria; Rizzi, Simonetta; Dan, Elisa; Sinigaglia, Barbara; Cavo, Michele; Terragna, Carolina | 2024-01-01 | CELLS | - | 1.01 Articolo in rivista | cells-13-00657-v2.pdf; cells-13-00657-s001.zip |
| High levels of CRBN isoform lacking IMiDs binding domain predicts for a worse response to IMiDs-based upfront therapy in newly diagnosed myeloma patients | Borsi E.; Mazzocchetti G.; Dico A.F.; Vigliotta I.; Martello M.; Poletti A.; Solli V.; Armuzzi S....; Taurisano B.; Kanapari A.; Pistis I.; Zamagni E.; Tacchetti P.; Pantani L.; Mancuso K.; Rocchi S.; Rizzello I.; Cavo M.; Terragna C. | 2023-01-01 | CLINICAL AND EXPERIMENTAL MEDICINE | - | 1.01 Articolo in rivista | s10238-023-01205-y.pdf; 10238_2023_1205_MOESM1_ESM.docx; 10238_2023_1205_MOESM2_ESM.docx |
| Impact of minimal residual disease standardised assessment by FDG-PET/CT in transplant-eligible patients with newly diagnosed multiple myeloma enrolled in the imaging sub-study of the FORTE trial | Zamagni E.; Oliva S.; Gay F.; Capra A.; Rota-Scalabrini D.; D'Agostino M.; Belotti A.; Galli M.; ...Racca M.; Zambello R.; Gamberi B.; Albano D.; Bertamini L.; Versari A.; Grasso M.; Sgherza N.; Priola C.; Fioritoni F.; Patriarca F.; De Cicco G.; Villanova T.; Pascarella A.; Zucchetta P.; Tacchetti P.; Fanti S.; Mancuso K.; Barbato S.; Boccadoro M.; Musto P.; Cavo M.; Nanni C. | 2023-01-01 | ECLINICALMEDICINE | - | 1.01 Articolo in rivista | PIIS2589537023001943.pdf; mmc1 (1).pdf |
| Long term follow-up of humoral and cellular response to mRNA-based vaccines for SARS-CoV-2 in patients with active multiple myeloma | Mancuso K.; Zamagni E.; Solli V.; Gabrielli L.; Leone M.; Pantani L.; Rocchi S.; Rizzello I.; Tac...chetti P.; Ghibellini S.; Favero E.; Ursi M.; Talarico M.; Barbato S.; Kanapari A.; Bigi F.; Puppi M.; Terragna C.; Borsi E.; Martello M.; Poletti A.; Scata A.; Nepoti G.; Ruffini B.; Lazzarotto T.; Cavo M. | 2023-01-01 | FRONTIERS IN ONCOLOGY | - | 1.01 Articolo in rivista | 2023 Mancuso K ematologia fonc-13-1208741.pdf; Data Sheet 1.docx |
| Multidisciplinary Management of Sternal Osteomyelitis Due to Klebsiella aerogenes after Open Heart Surgery in a Patient with Multiple Myeloma: A Case Report and Discussion of the Literature | Pignatti, Marco; Dolci, Giampiero; Zamagni, Elena; Pascale, Renato; Piccin, Ottavio; Ammar, Aless...andro; Zeneli, Flavia; Miralles, Maria Elisa Lozano; Mancuso, Katia; Cipriani, Riccardo; Viale, Pierluigi; Pacini, Davide; Martin-Suàrez, Sofia | 2023-01-01 | MICROORGANISMS | - | 1.01 Articolo in rivista | Multidisciplinary Management of Sternal Osteomyelitis Due to Klebsiella aerogenes after Open Heart Surgery in a Patient with Multiple Myeloma- A Case Report and Discussion of the Literature.pdf |
| Pomalidomide combinations are a safe and effective option after daratumumab failure | Annamaria Brioli; Laura Gengenbach; Katia Mancuso; Mascha Binder; Thomas Ernst; Florian H. Heidel...; Thomas Stauch; Elena Zamagni; Inken Hilgendorf; Andreas Hochhaus; Monika Engelhardt; Marie von Lilienfeld-Toal | 2023-01-01 | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY | - | 1.01 Articolo in rivista | Brioli_2023.pdf; 432_2023_4637_MOESM1_ESM.pdf |
| Prospective phase 2 trial of daratumumab with dexamethasone in patients with relapsed/refractory multiple myeloma and severe renal impairment or on dialysis: The DARE study | Kastritis E.; Terpos E.; Symeonidis A.; Labropoulou V.; Delimpasi S.; Mancuso K.; Zamagni E.; Kat...odritou E.; Rivolti E.; Kyrtsonis M.-C.; Roussou M.; Fotiou D.; Theodorakakou F.; Ntanasis-Stathopoulos I.; Hatjiharissi E.; Kanellias N.; Migkou M.; Cheliotis G.; Manousou K.; Gavriatopoulou M.; Dimopoulos M.A. | 2023-01-01 | AMERICAN JOURNAL OF HEMATOLOGY | - | 1.01 Articolo in rivista | - |
| Treatment of primary plasma cell leukaemia with carfilzomib and lenalidomide-based therapy (EMN12/HOVON-129): final analysis of a non-randomised, multicentre, phase 2 study | van de Donk NWCJ, Minnema MC, van der Holt B, Schjesvold F, Wu KL, Broijl A, Roeloffzen WWH, Gadi...sseur A, Pietrantuono G, Pour L, van der Velden VHJ, Lund T, Offidani M, Grasso M, Giaccone L, Razawy W, Tacchetti P, Mancuso K, Silkjaer T, Caers J, Zweegman S, Hájek R, Benjamin R, Vangsted AJ, Boccadoro M, Gay F, Sonneveld P, Musto P | 2023-01-01 | THE LANCET ONCOLOGY | - | 1.01 Articolo in rivista | EMN12_AM.pdf |
| Carfilzomib combined with lenalidomide and dexamethasone (KRd) as salvage therapy for multiple myeloma patients: italian, multicenter, retrospective clinical experience with 600 cases outside of controlled clinical trials | Martino E.A.; Conticello C.; Zamagni E.; Pavone V.; Palmieri S.; Musso M.; Tacchetti P.; Mele A.;... Catalano L.; Vigna E.; Bruzzese A.; Mendicino F.; Botta C.; Vincelli I.D.; Farina G.; Barone M.; Cangialosi C.; Mancuso K.; Rizziello I.; Rocchi S.; Falcone A.P.; Mele G.; Reddiconto G.; Garibaldi B.; Iaccino E.; Tripepi G.; Gamberi B.; Di Raimondo F.; Musto P.; Neri A.; Cavo M.; Morabito F.; Gentile M. | 2022-01-01 | HEMATOLOGICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Clonal and subclonal TP53 molecular impairment is associated with prognosis and progression in multiple myeloma | Martello M.; Poletti A.; Borsi E.; Solli V.; Dozza L.; Barbato S.; Zamagni E.; Tacchetti P.; Pant...ani L.; Mancuso K.; Vigliotta I.; Rizzello I.; Rocchi S.; Armuzzi S.; Testoni N.; Marzocchi G.; Martinelli G.; Cavo M.; Terragna C. | 2022-01-01 | BLOOD CANCER JOURNAL | - | 1.01 Articolo in rivista | s41408-022-00610-y.pdf; 41408_2022_610_MOESM1_ESM (1).docx |
| Identification of a Maturation Plasma Cell Index through a Highly Sensitive Droplet Digital PCR Assay Gene Expression Signature Validation in Newly Diagnosed Multiple Myeloma Patients | Martello M.; Solli V.; Termini R.; Kanapari A.; Remondini D.; Borsi E.; Poletti A.; Armuzzi S.; T...aurisano B.; Vigliotta I.; Mazzocchetti G.; Zamagni E.; Merlotti A.; Tacchetti P.; Pantani L.; Rocchi S.; Rizzello I.; Mancuso K.; Cavo M.; Terragna C. | 2022-01-01 | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | - | 1.01 Articolo in rivista | ijms-23-12450.pdf |
| Role of serum-free light chain assay for defining response and progression in immunoglobulin secretory multiple myeloma | Tacchetti P.; Rocchi S.; Zamagni E.; Barbato S.; Rizzello I.; De Cicco G.; Pantani L.; Mancuso K....; Fusco A.; Dozza L.; Ursi M.; Favero E.; Terragna C.; Testoni N.; Cavo M. | 2022-01-01 | AMERICAN JOURNAL OF HEMATOLOGY | - | 1.01 Articolo in rivista | American J Hematol - 2022 - Tacchetti - Role of serum‐free light chain assay for defining response and progression in.pdf |
| The ALLgorithMM: How to define the hemodilution of bone marrow samples in lymphoproliferative diseases | Vigliotta, Ilaria; Armuzzi, Silvia; Barone, Martina; Solli, Vincenza; Pistis, Ignazia; Borsi, Enr...ica; Taurisano, Barbara; Mazzocchetti, Gaia; Martello, Marina; Poletti, Andrea; Sartor, Chiara; Rizzello, Ilaria; Pantani, Lucia; Tacchetti, Paola; Papayannidis, Cristina; Mancuso, Katia; Rocchi, Serena; Zamagni, Elena; Curti, Antonio; Arpinati, Mario; Cavo, Michele; Terragna, Carolina | 2022-01-01 | FRONTIERS IN ONCOLOGY | - | 1.01 Articolo in rivista | fonc-12-1001048.pdf |
| A real-world efficacy and safety analysis of combined carfilzomib, lenalidomide, and dexamethasone (KRd) in relapsed/refractory multiple myeloma | Rocchi S.; Tacchetti P.; Pantani L.; Mancuso K.; Rizzello I.; di Giovanni Bezzi C.; Scalese M.; D...ozza L.; Marzocchi G.; Martello M.; Barila G.; Antonioli E.; Staderini M.; Buda G.; Petrini M.; Cea M.; Quaresima M.; Furlan A.; Bonalumi A.; Cavo M.; Zamagni E. | 2021-01-01 | HEMATOLOGICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |